Clinical relevance of serum vascular endothelial growth factor and Interleukin-6 in patients with colorectal cancer | Zendy

Ayman Eldesoky | Zendy; Ashraf Shouma | Zendy; Youssef M. Mosaad | Zendy; Amira Kamal El-Hawary | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Clinical relevance of serum vascular endothelial growth factor and Interleukin-6 in patients with colorectal cancer

Author(s) -

Ayman Eldesoky,

Ashraf Shouma,

Youssef M. Mosaad,

Amira Kamal El-Hawary

Publication year - 2011

Publication title -

saudi journal of gastroenterology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.608

H-Index - 32

eISSN - 1998-4049

pISSN - 1319-3767

DOI - 10.4103/1319-3767.80378

Subject(s) - medicine , clinical significance , colorectal cancer , angiogenesis , vascular endothelial growth factor , metastasis , stage (stratigraphy) , gastroenterology , oncology , cancer , vegf receptors , paleontology , biology

Some biological factors play a role in stimulation of malignant growth, metastasis and angiogenesis; however, their clinical relevance has not yet been well established for most of them. This work was aimed at studying the clinical relevance of serum vascular endothelial growth factor (VEGF) and interleukin-6 (IL-6), in patients with colorectal cancer (CRC).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research